BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20378239)

  • 1. The role of calprotectin in obstetrics and gynecology.
    Kostakis ID; Cholidou KG; Kallianidis K; Perrea D; Antsaklis A
    Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):3-9. PubMed ID: 20378239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
    Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
    Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophin in obstetrics and gynaecology.
    Bose CK
    J Stem Cells; 2009; 4(4):217-27. PubMed ID: 20720595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma calprotectin concentrations in women with endometrial carcinoma.
    Ni Bhriain H; Trovik J; Wik E; Stefansson IM; Akslen LA; Salvesen HB; Staff AC
    Gynecol Oncol; 2009 Sep; 114(3):491-5. PubMed ID: 19577278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.
    Ødegaard E; Davidson B; Elgaaen BV; Fagerhol MK; Engh V; Onsrud M; Staff AC
    Am J Obstet Gynecol; 2008 Apr; 198(4):418.e1-7. PubMed ID: 18241816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin plasma level is elevated in preeclampsia.
    Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of IGF I in gynecology and obstetrics].
    Bettahar-Lebugle K; Ohl J; Moreau L; Dellenbach P
    Contracept Fertil Sex; 1995 May; 23(5):302-6. PubMed ID: 7613575
    [No Abstract]   [Full Text] [Related]  

  • 9. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
    Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
    Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective view of obstetrics and gynecology over the past 40 years].
    Kaku M
    Kumamoto Igakkai Zasshi; 1969 Sep; 43(9):743-51. PubMed ID: 5394988
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of urocortin in gynecological and obstetrical conditions.
    Iavazzo C; Baka S; Malamitsi-Puchner A
    Arch Gynecol Obstet; 2009 May; 279(5):613-9. PubMed ID: 18777033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine networks and the regulation of uterine function in pregnancy and parturition.
    Orsi NM; Tribe RM
    J Neuroendocrinol; 2008 Apr; 20(4):462-9. PubMed ID: 18266939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prostaglandins in obstetrics/gynecology.
    Sherman AI
    Spec Top Endocrinol Metab; 1984; 6():141-61. PubMed ID: 6395414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the ras genes in female genital tract cancer.
    Mammas IN; Zafiropoulos A; Spandidos DA
    Int J Oncol; 2005 May; 26(5):1241-55. PubMed ID: 15809715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intercellular adhesion molecular 1, a diagnostic serum marker in chorioamnionitis, pre-eclampsia and HELLP syndrome].
    Steinborn A; Sohn C; Scharf A; Geka F; Haas S; Kaufmann M
    Z Geburtshilfe Neonatol; 2000; 204(4):140-5. PubMed ID: 11008336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
    Demir SC; Evruke C; Ozgunen FT; Urunsak IF; Candan E; Kadayifci O
    Saudi Med J; 2006 Jul; 27(7):1015-8. PubMed ID: 16830022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.